Facilitating tissue collection for translational research Jane Rogan Business Manager.

Slides:



Advertisements
Similar presentations
“Gifting Tissue for Research: An NHS Organisational Challenge”
Advertisements

UK Clinical Research Network (UKCRN) UK Clinical Research Network Maxine Stead PhD UKCRN Assistant Director – Clinical Trials.
Trust Cancer Lead Clinician
Clinical Dashboards – background information Clinical Dashboard - a “toolset developed to provide clinicians with the relevant and timely information they.
The National Cancer Intelligence Network An overview Professor David Forman Professor of Cancer Epidemiology, University of Leeds NCIN – Lead for Information.
Cancer Research UK STRATIFIED MEDICINE PROGRAMME
Procedures used by CHTN
Wrexham Maelor Lung Clinical Trials Overview February 2008.
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
Mesothelioma Collections September 2010 through September 2011.
Experimental Cancer Medicine – the future of cancer care Rosie Davies (LECMC RP based at RLUH) Janet Davies (LECMC RP based at CCO)
100k Genomes Project In December 2012 the Prime Minister announced a programme of Whole Genome Sequencing as part of the UK Government’s Life Sciences.
Metals in Medicine Consortium Sydney Cancer Centre.
1000 Lives Annual Report North of England Cancer Network Annual Conference 20 th September 2013.
Macmillan GP Facilitator for Walsall Dr Joo Ee Teoh, St Peter’s Surgery.
Tissue Banking Operations and Infrastructure Mid-Atlantic Pathologists Assistants and Pathologists Assistants of New England June 5 th 2009 Beacon Hotel,
The short term effects of an AKT inhibitor (AZD5363) on biomarkers of the AKT pathway and anti-tumour activity in a breast cancer paired biopsy study (STAKT.
Cancer Outcomes and Services Dataset Linda Wintersgill Information & Audit Manager, NECN.
Focus on NHS/Industry Morag McFarlane, PhD “World Leaders in Human Tissue Provision”
100k Genomes Project Programme of Whole Genome Sequencing, part of UK Life Sciences Strategy Aim to sequence 100,000 genomes from patients with cancer.
Delivering clinical research to make patients, and the NHS, better Cancer Patients’ Experiences of Research Findings from the National Cancer Patient Experience.
FRENCH high-resolution studies - Breast cancer: 1990, 1997, 2003, 2010 ? - Colorectal cancer: 1990, 1995, 2000, 2005, 2010 ? - Prostate cancer: 1995,
Cancer Outcomes and Services Dataset What is COSD? Implications for Providers and Networks.
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
Admissions of a non-admitted Access Policy Specialist Clinics Access Policy Implementation at Peter MacCallum Cancer Centre.
Neuroendocrine Tumour Biobank Dr Chrissie Thirlwell Cancer Research UK Clinician Scientist Senior Lecturer Medical Oncology Royal Free Hospital NET Unit.
Tissue Access for Patient Benefit Smoothing the pathway between patients, tissue donation, and research Consent Regulation Logistics Processing Allied.
The Bridge from Patient to Scientist Comparison: BioBank and Cancer Registry Data Source Distinct Patients Percent BioBank % Cancer Registry %
100,000 genomes project and haematological malignancy
SWAG SSG Skin Meeting Thursday 22nd September 2016 Maxine Taylor
SWAG SSG Sarcoma Meeting
NISCHR Academic Health Science Collaboration Launch
Genomic Medicine Centre Overview
SWAG SSG Skin Cancer Meeting
SWAG SSG Colorectal Cancer Meeting
West of England Genomic Medicine Centre
Integrated Performance Report 26 October 2017
SWAG SSG Upper GI Cancer Meeting
SWAG SSG Urology Cancer Meeting
SWAG SSG Upper GI Cancer Meeting
SWAG SSG Skin Cancer Meeting Tuesday 22nd May Research Report
West of England Genomic Medicine Centre: Our Progress to Date
SWAG SSG Colorectal Meeting
SWAG SSG Haematology and Lymphoma Meeting
SWAG SSG Sarcoma Cancer Meeting
Genomic Medicine Centre Overview
SWAG SSG Brain and CNS Cancer Meeting
Genomic Medicine Centre Overview
SWAG SSG Urology Meeting
SWAG SSG Lung Cancer Meeting
SWAG SSG Gynaecological Cancers Meeting
SWAG SSG Brain and CNS Cancer Meeting
SWAG SSG Skin Cancer Meeting
Mainstreaming Genomic Medicine post 100,000 Genomes Project
SWAG SSG Breast Cancer Meeting
SWAG SSG Sarcoma Meeting
SWAG SSG Head and neck Cancer Meeting
SWAG SSG Sarcoma Cancer Meeting
SWAG SSG Lung Cancer Meeting
SWAG SSG Skin Cancer Meeting Wednesday 23rd May Research Report
SWAG SSG Haematology and Lymphoma Cancer Meeting
Chris Wragg, Lead Cancer Scientist, SWGLH
Genomic Medicine Centre Overview
SWAG SSG Lung Cancer Meeting
SWAG SSG Skin Cancer Meeting
SWAG SSG Breast Cancer Meeting
SWAG SSG Upper GI Cancer Meeting
Lung Cancer Clinical Advisory Group
Living With & Beyond Cancer (Personalised Care): SWAG Colorectal CAG Update 5th June 2019 Catherine Neck, Macmillan Cancer Rehabilitation/ LWBC Lead On.
UAB Tissue Biorepository
Presentation transcript:

Facilitating tissue collection for translational research Jane Rogan Business Manager

MCRC Biobanking: The Basic Concept Make quality tissue collection and retrieval easy for the researcher Regulatory Framework Sample Collection Logistics Sample Quality Informatics Sample Access

Collaborating Trusts MCRC Biobank Pennine Acute Hospitals Trust The Christie NHS Foundation Trust South Manchester NHS Foundation Trust Salford Royal NHS Foundation Trust HPB Breast Colorectal Skin Urology Gynaecology Haematological Malignancies Lung Breast Head & Neck Colorectal Breast Upper GI Urology Neurology

Building a successful Biobank

Donations from over 6000 patients

Donations from 400 patients

Biobank Project Applications Total Applications: 86 Total Approved: 75 Average Approval Time: 30 working days (median)

The “Six-Pack” 1.Fresh Frozen Diseased Tissue 2.Fresh Frozen Non-involved Tissue 3.FFPE Disease Tissue 4.FFPE Non-involved Tissue 5.Pre-operative Blood sample 6.Pre-operative Urine sample

Melanoma Tissue Collection Pathway Collect Fresh From Theatres Fresh Cut-Up in Pathology Diagnostic Sample Research Sample Mouse model of tumour Frozen Tissue for Nucleic Acid Extraction Fixed Tissue for Staining

Evolving the Collections RequirementConsiderations Prospective Fresh Tissue Availability of tissue Staff available for sample delivery Media for keeping samples viable Use for Animal Models Specific consent for animal models Size of tumour tissue Alternative Sample Types (fluids, plucked hair) Routes / logistics of sample collection Serial Blood Collection inc CTCs Biobank Technician presence in clinic Past samples (e.g. pre- treatment/primary tumours) Specific consent Requesting blocks from local hospitals Sampling tumour in different areas Further input from pathology Clinical Trial Sample Collection Space for sample storage Different protocols for each trial

Biobank Projects by Type Total Approved Projects By Type Active Projects By Type (Total 33*)

Tissue Microarrays Current disease areas include prostate, bladder, lung Link to clinical databases Recently obtained Section 251 Support which allows the Biobank to link archival samples to clinical data Support through Surgical Oncology Research Theme – Data Manager employed

External Projects utilising Biobank Resource Stratified Medicine Programme – Phase 2 –Lung focus –Biopsy samples from late stage patients 100k Genome Project –Lung, Colorectal, Prostate TracerX –Facilitating sample collection MesoBank –Mesothelioma

Research Biopsies Working with clinical teams to introduce sample collection as a research only procedure How tumours change over time Comparing primary and metastatic tumours in patients Research into why patients are relapsing on targeted treatments Pilot to being in Malignant Melanoma

Key Success Drivers Established network model with existing infrastructure and pathways for sample collection Excellent clinical engagement across all cancer disease types Robust governance framework for tissue and data Proven track record of providing quality samples Research needs drive the sample collection, not the other way round

Thank you